6:25 PM
 | 
Sep 17, 2007
 |  BC Extra  |  Clinical News

AHRQ, FDA to study cardiovascular risks of ADHD drugs

The Department of Health and Human Services' Agency for Healthcare Research and Quality and FDA will collaborate to study ADHD drugs and the potential for...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >